1. Home
  2. HUBCW vs VCEL Comparison

HUBCW vs VCEL Comparison

Compare HUBCW & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBCW
  • VCEL
  • Stock Information
  • Founded
  • HUBCW N/A
  • VCEL 1989
  • Country
  • HUBCW Israel
  • VCEL United States
  • Employees
  • HUBCW 322
  • VCEL N/A
  • Industry
  • HUBCW
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HUBCW
  • VCEL Health Care
  • Exchange
  • HUBCW Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • HUBCW N/A
  • VCEL 2.1B
  • IPO Year
  • HUBCW N/A
  • VCEL 1997
  • Fundamental
  • Price
  • HUBCW $0.03
  • VCEL $41.46
  • Analyst Decision
  • HUBCW
  • VCEL Strong Buy
  • Analyst Count
  • HUBCW 0
  • VCEL 8
  • Target Price
  • HUBCW N/A
  • VCEL $62.00
  • AVG Volume (30 Days)
  • HUBCW N/A
  • VCEL 450.2K
  • Earning Date
  • HUBCW N/A
  • VCEL 07-31-2025
  • Dividend Yield
  • HUBCW N/A
  • VCEL N/A
  • EPS Growth
  • HUBCW N/A
  • VCEL 521.85
  • EPS
  • HUBCW N/A
  • VCEL 0.05
  • Revenue
  • HUBCW N/A
  • VCEL $238,541,000.00
  • Revenue This Year
  • HUBCW N/A
  • VCEL $23.03
  • Revenue Next Year
  • HUBCW N/A
  • VCEL $24.52
  • P/E Ratio
  • HUBCW N/A
  • VCEL $702.91
  • Revenue Growth
  • HUBCW N/A
  • VCEL 14.80
  • 52 Week Low
  • HUBCW N/A
  • VCEL $37.39
  • 52 Week High
  • HUBCW N/A
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • HUBCW N/A
  • VCEL 46.36
  • Support Level
  • HUBCW N/A
  • VCEL $40.53
  • Resistance Level
  • HUBCW N/A
  • VCEL $43.57
  • Average True Range (ATR)
  • HUBCW 0.00
  • VCEL 1.70
  • MACD
  • HUBCW 0.00
  • VCEL -0.12
  • Stochastic Oscillator
  • HUBCW 0.00
  • VCEL 34.04

About HUBCW Hub Cyber Security Ltd. Warrant 2/27/28

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: